News

• 2026.05.12
  Financial Results(決算資料)
  Supplemental Materials for the First Half of FY9/26 Consolidated Financial Results
• 2026.05.12
  Financial Results(決算資料)
  Financial Results of 2Q/FY2026
• 2026.05.12
  Financial Results(決算資料)
  Notice Regarding Loss on Valuation of Securities for the Second Quarter of the Fiscal Year ending September 2026

• 2026.05.12
  Financial Results
  Supplemental Materials for the First Half of FY9/26 Consolidated Financial Results
• 2026.05.12
  Financial Results
  Financial Results of 2Q/FY2026
• 2026.05.12
  Financial Results
  Notice Regarding Loss on Valuation of Securities for the Second Quarter of the Fiscal Year ending September 2026

• 2026.05.11
  Release
  OLIC Thailand Commences Promotional Activities for "Papilocare® Vaginal Gel"
• 2026.03.24
  Release
  Fuji Pharma and Gedeon Richter Conclude Agreement for Joint Development Projects in Women's Health
• 2026.03.19
  Release
  Notice Regarding Revision of Interim Dividend Forecasts for the Fiscal Year Ending September2026 (62ndFiscal Year)

• 2025.07.25
  Product
  Initiation of Phase Ⅲ clinical trial for the Alyssa® combination tablets
• 2025.06.25
  Product
  Emergency contraceptive pill : LEVONORGESTREL tablet 1.5 mg "F" Notice of Application for Marketing Approval as Switch OTC Drug
• 2019.10.23
  Product
  Manufacturing and marketing approval succession for l'estrogel 0.06% treatment for menopausal disorders

• 2026.01.27
  Other
  FY2025 Company Research and Analysis Report (Published by FISCO Ltd.)
• 2025.11.27
  Other
  Notice of the 61th Ordinary General Meeting of Shareholders
• 2025.08.22
  Other
  Corporate Report 2025 (English version) has been published